-
Forward Look
Genetic Testing Can Help Women With Triple-Negative Breast CancerStudy confirms inherited genetic mutations are common, regardless of family history.
by Kendall K. Morgan
-
Forward Look
Medicare to Cover Lung Cancer ScreeningIn high-risk current and former smokers, screening can reduce cancer deaths.
by Michael Eisenstein
-
Forward Look
Does Testicular Cancer Screening Save Lives?Doctors recommend self-exam, even though guidelines discourage it.
by Roxanne Nelson
-
Genomic Testing: The Risk of Knowing Too MuchSophisticated tests can generate a wealth of information about a patient's cancer or disease risk. But they also raise serious questions.
by Alexandra Goho
-
A Dose of PrecisionStereotactic radiation therapy–heavily marketed to consumers–is gaining momentum as a more convenient treatment. But it's not for every patient.
by Sharon Reynolds
-
Healthy Habits
A Cup of Tea?Black tea consumption may be associated with a reduced risk of ovarian cancer.
by Kurt Ullman
-
Forward Look
National Clinical Trials Network Now UnderwayRevamped program aims to get new treatments to patients faster.
by Michael Eisenstein
-
Forward Look
A Champion for PreventionQ&A with Elmer Huerta, the director of the Cancer Preventorium at MedStar Washington Hospital Center
by Sue Rochman
-
Forward Look
Personalizing Prostate Cancer TreatmentActive surveillance may not be right for all African-American men with low-grade prostate cancer.
by Stephen Ornes
-
Lighting a Fire Under Tobacco-Related CancersAs researchers unravel the extent and scientific underpinnings of tobacco-related cancers and addiction, patients can seek support to quit tobacco or cope with the stigma often associated with these cancers.
by Stephen Ornes
After caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
